7 Followers USX:TWST - Twist Bioscience Corporation Twist Bioscience Corporation
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 116.74    +5.490 (+4.93%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

21 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Emily Marine Leproust

IPO: 2018-10-31

Headquarters: US

Employees: 525

Homepage

Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.